2M7C Stock Overview
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
China Medical System Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.81 |
| 52 Week High | HK$1.76 |
| 52 Week Low | HK$0.77 |
| Beta | 0.80 |
| 1 Month Change | -40.07% |
| 3 Month Change | -37.79% |
| 1 Year Change | -47.08% |
| 3 Year Change | -55.46% |
| 5 Year Change | 4.09% |
| Change since IPO | 187.24% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2M7C | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -0.6% | -2.9% | -2.5% |
| 1Y | -47.1% | -31.3% | -0.4% |
Return vs Industry: 2M7C underperformed the German Pharmaceuticals industry which returned -31.3% over the past year.
Return vs Market: 2M7C underperformed the German Market which returned -0.4% over the past year.
Price Volatility
| 2M7C volatility | |
|---|---|
| 2M7C Average Weekly Movement | 11.3% |
| Pharmaceuticals Industry Average Movement | 7.0% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2M7C's share price has been volatile over the past 3 months.
Volatility Over Time: 2M7C's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 5,701 | Kong Lam | web.cms.net.cn/zh/home/ |
China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company’s products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn’s disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar. It also offers DanShenTong capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu for treating respiratory diseases; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications.
China Medical System Holdings Limited Fundamentals Summary
| 2M7C fundamental statistics | |
|---|---|
| Market cap | €2.07b |
| Earnings (TTM) | €311.63m |
| Revenue (TTM) | €1.04b |
6.6x
P/E Ratio2.0x
P/S RatioIs 2M7C overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2M7C income statement (TTM) | |
|---|---|
| Revenue | CN¥8.01b |
| Cost of Revenue | CN¥1.94b |
| Gross Profit | CN¥6.08b |
| Other Expenses | CN¥3.68b |
| Earnings | CN¥2.40b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.98 |
| Gross Margin | 75.82% |
| Net Profit Margin | 29.96% |
| Debt/Equity Ratio | 8.2% |
How did 2M7C perform over the long term?
See historical performance and comparisonDividends
6.0%
Current Dividend Yield40%
Payout RatioDoes 2M7C pay a reliable dividends?
See 2M7C dividend history and benchmarks| China Medical System Holdings dividend dates | |
|---|---|
| Ex Dividend Date | May 13 2024 |
| Dividend Pay Date | May 23 2024 |
| Days until Ex dividend | 24 days |
| Days until Dividend pay date | 34 days |
Does 2M7C pay a reliable dividends?
See 2M7C dividend history and benchmarks